These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

357 related items for PubMed ID: 17541639

  • 21. Primary vaccination of infants against hepatitis B can be completed using a combined hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliomyelitis-Haemophilus influenzae type B vaccine.
    Lim FS, Han HH, Jacquet JM, Bock HL.
    Ann Acad Med Singap; 2007 Oct; 36(10):801-6. PubMed ID: 17987229
    [Abstract] [Full Text] [Related]

  • 22. The immunogenicity and safety of a tetravalent measles-mumps-rubella-varicella vaccine when co-administered with conjugated meningococcal C vaccine to healthy children: A phase IIIb, randomized, multi-center study in Italy.
    Durando P, Esposito S, Bona G, Cuccia M, Desole MG, Ferrera G, Gabutti G, Pellegrino A, Salvini F, Henry O, Povey M, Marchetti F.
    Vaccine; 2016 Aug 05; 34(36):4278-84. PubMed ID: 27423382
    [Abstract] [Full Text] [Related]

  • 23. Immunogenicity and reactogenicity of a novel hexavalent DTPa-HBV-IPV/Hib vaccine compared to separate concomitant injections of DTPa-IPV/Hib and HBV vaccines, when administered according to a 3, 5 and 11 month vaccination schedule.
    Avdicová M, Prikazský V, Hudecková H, Schuerman L, Willems P.
    Eur J Pediatr; 2002 Nov 05; 161(11):581-7. PubMed ID: 12424582
    [Abstract] [Full Text] [Related]

  • 24. Immunogenicity and Reactogenicity of DTPa-HBV-IPV/Hib and PHiD-CV When Coadministered With MenACWY-TT in Infants: Results of an Open, Randomized Trial.
    Merino Arribas JM, Carmona Martínez A, Horn M, Perez Porcuna XM, Otero Reigada MDC, Marès Bermúdez J, Centeno Malfaz F, Miranda M, Mendez M, Garcia Cabezas MA, Christoph W, Bleckmann G, Fischbach T, Kolhe D, Van der Wielen M, Baine Y.
    Pediatr Infect Dis J; 2018 Jul 05; 37(7):704-714. PubMed ID: 29620722
    [Abstract] [Full Text] [Related]

  • 25. A second dose of a measles-mumps-rubella vaccine administered to healthy four-to-six-year-old children: a phase III, observer-blind, randomized, safety and immunogenicity study comparing GSK MMR and MMR II with and without DTaP-IPV and varicella vaccines co-administration.
    MMR-158 Study Groupa See Contributors section..
    Hum Vaccin Immunother; 2019 Jul 05; 15(4):786-799. PubMed ID: 30785357
    [Abstract] [Full Text] [Related]

  • 26. Safety and immunogenicity of early vaccination with two doses of tetravalent measles-mumps-rubella-varicella (MMRV) vaccine in healthy children from 9 months of age.
    Goh P, Lim FS, Han HH, Willems P.
    Infection; 2007 Oct 05; 35(5):326-33. PubMed ID: 17710370
    [Abstract] [Full Text] [Related]

  • 27. Investigation of an increase in large local reactions following vaccine schedule change to include DTaP-HB-IPV-Hib (Infanrix-hexa®) and MMRV (ProQuad®) at 18 months of age.
    Kiely M, Billard MN, Toth E, Zafack JG, Landry M, Skowronski DM, De Serres G.
    Vaccine; 2018 Oct 29; 36(45):6688-6694. PubMed ID: 30269915
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Booster vaccination with hexavalent DTPa-HBV-IPV/Hib vaccine in the second year of life is as safe as concomitant DTPa-IPV/Hib + HBV administered separately.
    Saenger R, Maechler G, Potreck M, Zepp F, Knuf M, Habermehl P, Schuerman L.
    Vaccine; 2005 Jan 19; 23(9):1135-43. PubMed ID: 15629356
    [Abstract] [Full Text] [Related]

  • 32. Disparate kinetics in immune response of two different Haemophilus influenzae type b conjugate vaccines: Immunogenicity and safety observations from a randomized controlled phase IV study in healthy infants and toddlers using a 2+1 schedule.
    Martinón-Torres F, Salamanca de la Cueva I, Horn M, Westerholt S, Bosis S, Meyer N, Cheuvart B, Virk N, Jakes RW, Duchenne M, Van den Steen P.
    Hum Vaccin Immunother; 2024 Dec 31; 20(1):2342630. PubMed ID: 38687024
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Safety and reactogenicity of DTPa-HBV-IPV/Hib and DTPa-IPV/I-Hib vaccines in a post-marketing surveillance setting.
    Lim FS, Phua KB, Lee BW, Quak SH, Teoh YL, Ramakrishnan G, Han HH, Van Der Meeren O, Jacquets JM, Bock HL.
    Southeast Asian J Trop Med Public Health; 2011 Jan 31; 42(1):138-47. PubMed ID: 21323176
    [Abstract] [Full Text] [Related]

  • 35. Safety, immunogenicity and persistence of immune response to the combined diphtheria, tetanus, acellular pertussis, poliovirus and Haemophilus influenzae type b conjugate vaccine (DTPa-IPV/Hib) administered in Chinese infants.
    Li Y, Li RC, Ye Q, Li C, Liu YP, Ma X, Li Y, Zhao H, Chen X, Assudani D, Karkada N, Han HH, Van Der Meeren O, Mesaros N.
    Hum Vaccin Immunother; 2017 Mar 04; 13(3):588-598. PubMed ID: 27768515
    [Abstract] [Full Text] [Related]

  • 36. Immunogenicity, Safety and Reactogenicity of a Booster Dose of the 10-Valent Pneumococcal Nontypeable H. influenzae Protein D Conjugate Vaccine Coadministered With DTPa-IPV-Hib in Dutch Children: A Randomized Controlled Trial.
    van den Bergh MR, Spijkerman J, François N, Swinnen K, Borys D, Schuerman L, Veenhoven RH, Sanders EA.
    Pediatr Infect Dis J; 2016 Jul 04; 35(7):e206-19. PubMed ID: 27097348
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Immunogenicity and reactogenicity of a booster dose of diphtheria, tetanus, acellular pertussis and inactivated poliomyelitis vaccines given concurrently with Haemophilus type b conjugate vaccine or as pentavalent vaccine.
    Bégué P, Stagnara J, Vie-Le-Sage F, Bernard JC, Xerri B, Abitbol V.
    Pediatr Infect Dis J; 1997 Aug 04; 16(8):787-94. PubMed ID: 9271042
    [Abstract] [Full Text] [Related]

  • 40. Antibody responses of healthy infants to concurrent administration of a bivalent haemophilus influenzae type b-hepatitis B vaccine with diphtheria-tetanus-pertussis, polio and measles-mumps-rubella vaccines.
    West DJ, Rabalais GP, Watson B, Keyserling HL, Matthews H, Hesley TM.
    BioDrugs; 2001 Aug 04; 15(6):413-8. PubMed ID: 11520252
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.